C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines
DOI:
https://doi.org/10.17140/VROJ-1-102Abstract
In casual conversation with non-medical individuals, it is common for them to ask: why do we not have a cure for cancer or vaccinations for all diseases? It seems somewhat logical to assume that after so many years of research that cures should be readily available, diseases in general should simply require a pill or jab and that somehow, if scientists are not deliberately hiding these cures, then they must be asleep at the wheel. A typical response to such questions focuses on the complexity of the different cancers/diseases and that there will be no “one cure fits all”. When it comes to vaccinations, there is absolutely no doubt that many vaccines are extremely effective and a multitude of publications can attest to this and cite how many lives have been saved because of our vaccination programs; indeed, vaccinations typically pop up on a list of reasons why humans today are living substantially longer than at any previous time in history.1-3 Nevertheless, there is always an overriding and to some extent embarrassing realization that despite the relative success of vaccines we still do not, for the most part, know how to make consistently effective vaccines and that often it boils down to a trial and error procedure to establish the best vaccine for a given target.
References
Andre FE, Booy R, Bock HL, J, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008; 86(2): 140-146. doi: 10.1590/ S0042-96862008000200016
Plotkin S. History of vaccination. Proc Natl Acad Sci U S A. 2014; 111(34): 12283-12287. doi: 10.1073/pnas.1400472111
Rappuoli R. Inner Workings: 1885, the first rabies vaccina-tion in humans. Proc Natl Acad Sci U S A. 2014; 111(34): 12273. doi: 10.1073/pnas.1414226111
Campbell JJ, Bowman EP, Murphy K, et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol. 1998; 141(4): 1053-1059. doi: 10.1083/ jcb.141.4.1053
Förster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional mi-croenvironments in secondary lymphoid organs. Cell. 1999; 99(1): 23-33. doi: 10.1016/S0092-8674(00)80059-8
Gunn MD, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lym-phocyte homing and dendritic cell localization. J Exp Med. 1999; 189(3): 451-460. doi: 10.1084/jem.189.3.451
Okada T, Cyster JG. CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph node. J Immunol. 2007; 178(5): 2973-2978. doi: 10.4049/jimmunol.178.5.2973
Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kaki-uchi T. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med. 2001; 193(2): 207-218. doi: 10.1084/jem.193.2.207
Moschovakis GL, Bubke A, Dittrich-Breiholz O, et al. De-ficient CCR7 signaling promotes TH2 polarization and B-cell activation in vivo. Eur J Immunol. 2012; 42(1): 48-57. doi:
1002/eji.201141753 10. Garcia de Vinuesa C, MacLennan IC, Holman M, Klaus GG. Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help. Eur J Im-munol. 1999; 29(10): 3216-3224. doi: 10.1002/(SICI)1521- 4141(199910)29:10<3216::AID-IMMU3216>3.0.CO;2-X
Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001; 14(5): 617- 629. doi: 10.1016/S1074-7613(01)00129-7
Achtman, AH, Höpken UE, Bernert C, Lipp M. CCR7- deficient mice develop atypically persistent germinal centers in response to thymus-independent type 2 antigens. J Leukoc Biol. 2009; 85(3): 409-417. doi: 10.1189/jlb.0308162
Bardi G, Lipp M, Baggiolini M, Loetscher P. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC. Eur J Immunol. 2001; 31(11): 3291- 3297. doi: 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO;2-Z
Byers MA, Calloway PA, Shannon L, et al. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J Immunol. 2008; 181(7): 4723-4732. doi: 10.4049/ jimmunol.181.7.4723
Shannon LA, McBurney TM, Wells MA, et al. CCR7/ CCL19 controls expression of EDG-1 in T cells. J Biol Chem. 2012; 287(15): 11656-11664. doi: 10.1074/jbc.M111.310045
Hauser MA, Legler DF. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its li-gands CCL19 and CCL21 in leukocytes. J Leukoc Biol. 2016; pii: jlb.2MR0815-380R. doi: 10.1189/jlb.2MR0815-380R
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Vaccination Research (VR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.